These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 7282106
1. [Current status of D-penicillamine therapy in chronic polyarthritis]. Franke M, Menning H, Ströbel G. Z Rheumatol; 1981; 40(2):54-61. PubMed ID: 7282106 [Abstract] [Full Text] [Related]
2. [D-penicillamine--a current review of areas of use and dosage guidelines]. Sörensen H. Z Rheumatol; 1988; 47 Suppl 1():13-6. PubMed ID: 3063002 [Abstract] [Full Text] [Related]
3. [Antibodies to D-penicillamine in patients with chronic polyarthritis--diagnostic aid in undesired and insufficient drug effects?]. Storch W, Keitel W. Z Rheumatol; 1988; 47 Suppl 1():44-7. PubMed ID: 3213272 [Abstract] [Full Text] [Related]
4. [Effectiveness and limits of D-penicillamine therapy]. Behrend T, Eisterhues C, Behrend M. Z Rheumatol; 1988; 47 Suppl 1():28-33. PubMed ID: 3213269 [Abstract] [Full Text] [Related]
5. [Is myositis in chronic polyarthritis using d-penicillamine drug-induced?]. Schlumpf U, Bussmann HU, Jerusalem F. Schweiz Med Wochenschr; 1981 Jan 03; 111(1):29-35. PubMed ID: 6782670 [Abstract] [Full Text] [Related]
6. The side effects of penicillamine therapy in rheumatoid arthritis. Huskisson EC. J Rheumatol Suppl; 1981 Jan 03; 7():146-8. PubMed ID: 6939876 [Abstract] [Full Text] [Related]
7. [D-penicillamine--side effects, pathogenesis and decreasing the risks]. Grasedyck K. Z Rheumatol; 1988 Jan 03; 47 Suppl 1():17-9. PubMed ID: 3063003 [Abstract] [Full Text] [Related]
8. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine. Redda A, Anastassiades T. Clin Invest Med; 1984 Jan 03; 7(1):65-71. PubMed ID: 6426836 [Abstract] [Full Text] [Related]
9. [Early recognition of adverse effects, especially of kidney lesions, in patients with progressive chronic polyarthritis under D-Penicillamine therapy]. Otto W, Pietruschka WD, Beenken O. Z Gesamte Inn Med; 1975 Aug 01; 30(15):507-9. PubMed ID: 1189496 [Abstract] [Full Text] [Related]
11. Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis. Hakoda M, Taniguchi A, Kamatani N, Akahoshi T, Kashiwazaki S. J Rheumatol; 1994 Sep 01; 21(9):1637-41. PubMed ID: 7799341 [Abstract] [Full Text] [Related]
12. [Use of cyclosporin A in chronic polyarthritis and other rheumatic diseases]. Krüger K. Z Rheumatol; 1995 Sep 01; 54(2):89-95. PubMed ID: 7793161 [Abstract] [Full Text] [Related]
14. The effect of D-penicillamine on plasma amino acids in rheumatoid arthritis. Partsch G, Tausch G, Neuwirth E, Neumüller J. Z Rheumatol; 1983 Sep 01; 42(3):126-9. PubMed ID: 6880413 [Abstract] [Full Text] [Related]
15. [D-penicillamine in the treatment of rheumatoid polyarthritis. 104 cases with a 5-year follow-up]. Valat JP, Fouquet B, Eveleigh MC, Chantreuil C, Lalot F. Rev Rhum Mal Osteoartic; 1986 Jan 01; 53(1):7-12. PubMed ID: 3704516 [Abstract] [Full Text] [Related]
17. [Acadione, a new long-term treatment of rheumatoid polyarthritis]. Amor B, Mery C, de Gery A. Rev Rhum Mal Osteoartic; 1988 Apr 30; 55(6):462-6. PubMed ID: 3393845 [Abstract] [Full Text] [Related]
18. [3 cases of obliterating bronchiolitis during treatment of rheumatoid polyarthritis with D-penicillamine]. Renier JC, Bontoux-Carre E, Racineux JL. Rev Rhum Mal Osteoartic; 1986 Jan 30; 53(1):25-6. PubMed ID: 3704508 [Abstract] [Full Text] [Related]
20. [Lupus biology: incidence and development in 84 rheumatoid polyarthritis patients treated with D-penicillamine]. Clerc D, Sallière D, Segond P, Bisson M, Massias P. Ann Med Interne (Paris); 1984 Jan 30; 135(6):420-6. PubMed ID: 6334465 [Abstract] [Full Text] [Related] Page: [Next] [New Search]